TICAGRELOR | N022433 | ASTRAZENECA PHARMACEUTICALS LP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
AstraZeneca AB et al v. Alembic Pharmaceuticals Ltd. et al 1 patentANDA 208576ticagrelor | D. Del. | 2022-09-16 | Terminated 2022-12-30 | — |
ASTRAZENECA LP et al v. DR. REDDY'S LABORATORIES, LTD. et al 2 patentsANDA 208541ticagrelor | D.N.J. | 2019-07-23 | Terminated 2020-03-26 | — |
| D. Del. | 2017-11-13 | Terminated 2019-01-02 | — | |
| D. Del. | 2015-11-16 | Terminated 2019-01-02 | — | |
| D. Del. | 2015-11-12 | Terminated 2016-08-24 | — | |
AstraZeneca LP et al v. Hisun Pharmaceutical (Hangzhou) Co., Ltd. et al 1 patentANDA 208575ticagrelor | D. Del. | 2015-11-12 | Terminated 2016-02-04 | — |
| WVND | 2015-11-02 | Terminated 2017-07-19 | — | |
| NYED | 2015-11-02 | Terminated 2015-12-18 | — | |
| D. Del. | 2015-10-30 | Terminated 2018-03-09 | — | |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. 1 patentANDA 208576ticagrelor | D. Del. | 2015-10-30 | Terminated 2015-11-12 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).